Improving survival rates for adolescents and young adults with cancer.
Of brain and other nervous system cancer diagnoses from 2004-2008 approximately 12.9% were diagnosed under the age of 20, 8.9% between 20 and 34, and 9.6% between 35 and 44. Common symptoms of such diseases among the young adult population include headache, vomiting, alteration in mood, limb weakness, bladder/bowel dysfunction, and seizures.
Source: Bleyer A. CAUTION! Consider Cancer: Common Symptoms and Signs for Early Detection of Cancer in Young Adults. Semin Oncol. 2009; 36:207-21. SEER: http://seer.cancer.gov/statfacts/html/brain.html
End of life care in adolescents and young adults with cancer: Experience of the adolescent unit of the Institut Gustave Roussy.
Eur J Cancer. 2011 Nov 2;
Authors: Cohen-Gogo S, Marioni G, Laurent S, Gaspar N, Semeraro M, Gabolde M, Dufour C, Valteau-Couanet D, Brugières L
Abstract
BACKGROUND: Cancer is the third leading cause of death in adolescents and young adults (AYA). Little is known, however, about how end-of-life unfolds for those who die of progressive disease. In order to...
Congenital tumors of the central nervous system: the MCH experience.
Pediatr Neurosurg. 2009;45(5):368-74
Authors: Shamji MF, Vassilyadi M, Lam CH, Montes JL, Farmer JP
Congenital brain tumors in the younger pediatric population are rare lesions that are histologically distinct from those in the older pediatric population. Malignant histology is common, with persistently poor outcomes despite accessible neuroimaging and evolving adjuvant therapy. There remains scant literature about the natural...
Best cases from the AFIP: glioblastoma multiforme.
Radiographics. 2007 May-Jun;27(3):883-8
Authors: Altman DA, Atkinson DS, Brat DJ
PMID: 17495298 [PubMed - indexed for MEDLINE]
Endovascular restorative neurosurgery: a novel concept for molecular and cellular therapy of the nervous system.
Neurosurgery. 2003 Feb;52(2):402-12; discussion 412-3
Authors: Amar AP, Zlokovic BV, Apuzzo ML
The amalgam of molecular biology and neurosurgery offers immense promise for neurorestoration and the management of neurodegenerative deficiencies, developmental disorders, neoplasms, stroke, and trauma. This article summarizes present strategies for and impediments to gene therapy and stem...
Predictive value of serum prolactin levels measured immediately after transsphenoidal surgery.
J Neurosurg. 2002 Aug;97(2):307-14
Authors: Amar AP, Couldwell WT, Chen JC, Weiss MH
Prolactin-secreting pituitary adenomas may be managed by surgery, medication, radiotherapy, or observation. The authors reviewed a consecutive series of patients who were followed for at least 5 years after surgery to assess the prognostic significance of preoperative factors (tumor size and prolactin level) and an...
from patients, caregivers and medical professionals dealing with this disease and many other diseases
Share This Tip